Fullerton Management Pte Ltd
CIK 1379348 · last filed 2019-10-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
PTLA price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
THE ATRIUM@ORCHARD
SINGAPORE, U0 238891
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VIR | 10%+ Owner | 3,333,333 | $10.43 | $34.77M | $50.00M | 1 | 2019-10-18 |
| GH | 10%+ Owner | 596,012 | $162.94 | $97.11M | $0 | 1 | 2018-10-11 |
| PORTOLA PHARMACEUTICALS INC (PTLA) Delisted | 10%+ Owner | 10,717,136 | — | — | -$161.92M | 2 | 2017-06-05 |
| AMYRIS, INC. (AMRS) Delisted | 10%+ Owner | 3,302,585 | $0.05 | $165.1K | -$18.35M | 10 | 2017-04-21 |
| Fresh Tracks Therapeutics, Inc. (VICL) Delisted | 10%+ Owner | 58,510 | — | — | -$4.85M | 4 | 2009-05-22 |
Recent Filings · Page 2 of 2
18 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-11-09 | AMYRIS, INC. (AMRS) Delisted | Sell (S) | −1,335,244 | -$1.09M | EDGAR |
| 2016-11-07 | AMYRIS, INC. (AMRS) Delisted | Sell (S) | −10,444,932 | -$9.30M | EDGAR |
| 2015-12-10 | PORTOLA PHARMACEUTICALS INC (PTLA) Delisted | Buy (P) | +1,500,000 | $72.00M | EDGAR |
| 2015-07-30 | AMYRIS, INC. (AMRS) Delisted | Mixed | +123,442,532 | $283.92M | EDGAR |
| 2009-05-22 | Fresh Tracks Therapeutics, Inc. (VICL) Delisted | Sell (S) | −260,992 | -$684.6K | EDGAR |
| 2009-05-20 | Fresh Tracks Therapeutics, Inc. (VICL) Delisted | Sell (S) | −179,120 | -$403.4K | EDGAR |
| 2009-05-18 | Fresh Tracks Therapeutics, Inc. (VICL) Delisted | Sell (S) | −274,416 | -$618.2K | EDGAR |
| 2009-04-30 | Fresh Tracks Therapeutics, Inc. (VICL) Delisted | Sell (S) | −1,289,640 | -$3.14M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.